Josée Zijlstra

34PUBLICATIONS
142CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jun 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

|Feb 14, 2026
A Lesion-adaptive Segmentation Approach for Tumor Delineation on FDG PET/CT in Diffuse Large B-cell Lymphoma Patients.

Gerben J C Zwezerijnen, Martijn W Heymans, Danielle van Assema

|Feb 09, 2026
MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

Jan-Michel Heger, Julia Mattlener, Helen Kaul

|Sep 13, 2025
Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment Effects.

Shahin Roshani, Flora E van Leeuwen, Sara Rossetti

|Aug 18, 2025
Can we obtain prognostic information from healthy tissue uptake and volume in baseline 18F-FDG PET/CT imaging in diffuse large B-cell lymphoma?

Nienke R Gerards, Sanne E Wiegers, Anne L Bes

|Jun 05, 2025
Attendance at survivorship clinics in relation to Hodgkin lymphoma survivor and treatment characteristics.

Eline M J Lammers, Berthe M P Aleman, Michael Schaapveld

Pageof 6

Frequent Collaborators

14 joint publications

Gerben Jc Zwezerijnen

12 joint publications

Pieternella J Lugtenburg

11 joint publications

Jakoba J Eertink

10 joint publications

Sanne E Wiegers